Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Relapsed or Refractory Non-Hodgkin's Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Contact: Study coordinator (Xin Li, Dr.) · 972978226@qq.com · 13808418932
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Depei Wu, Dr.) · wudepei@suda.edu.cn · 0512-67781856
Contact: Study coordinator (Liqing Kang, Dr.) · liqing.kang@unicar-therapy.com · 13162512992

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

Acute Lymphoblastic Leukemia · Non-Hodgkin's Lymphoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China